Clinical Trials Browser

Interventional × Urologic Neoplasms × pembrolizumab × Clear all

NCT06353906 2025-12-08

PRIAM

Phase 2 Recruiting

Penile Neoplasms, Urogenital Neoplasms, Urologic Neoplasms, Male Urogenital Diseases

NCT03288545 2025-11-10

EV-103

Phase 1/2 Active not recruiting

348 enrolled 1 FDA

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell, Ureteral Neoplasms, Urethral Neoplasms, Urologic Neoplasms

NCT03435952 2025-10-14

Pembrolizumab With Intratumoral Injection of Clostridium Novyi-NT

Phase 1 Active not recruiting

BreastGenitourinary

Breast Neoplasms, Urologic Neoplasms

NCT04931979 2023-03-01

Pembro-SRT

Phase 2 Recruiting

Urologic Neoplasms